Core Insights - Cannara Biotech Inc. has qualified to trade on the OTCQX® Best Market, upgrading from the OTCQB® Venture Market, which signifies a milestone for the company in enhancing visibility among U.S. investors [1][3][4] Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products, operating two mega facilities in Québec with a total area of over 1,650,000 square feet, allowing for a potential annual cultivation output of 100,000 kg [5] - The company leverages Québec's low electricity costs to produce affordable premium-grade cannabis products [5] Market Context - The OTCQX Market is designed for established, investor-focused companies that meet high financial standards and corporate governance practices, which Cannara has successfully achieved [3] - The upgrade to OTCQX is expected to support Cannara's long-term capital markets strategy by enhancing its visibility and credibility with U.S. investors [4]
OTC Markets Group Welcomes Cannara Biotech Inc. to OTCQX
Globenewswire·2026-01-14 12:00